These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19195665)
1. Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy. Petzold A; Thompson EJ; Keir G; Quinn N; Holmberg B; Dizdar N; Wenning GK; Rascol O; Tolosa E; Rosengren L J Neurol Sci; 2009 Apr; 279(1-2):76-9. PubMed ID: 19195665 [TBL] [Abstract][Full Text] [Related]
2. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. Holmberg B; Rosengren L; Karlsson JE; Johnels B Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329 [TBL] [Abstract][Full Text] [Related]
3. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease. Abdo WF; Bloem BR; Van Geel WJ; Esselink RA; Verbeek MM Neurobiol Aging; 2007 May; 28(5):742-7. PubMed ID: 16678934 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of CSF neurofilament light and heavy chain protein in MS. Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999 [TBL] [Abstract][Full Text] [Related]
5. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes. Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909 [TBL] [Abstract][Full Text] [Related]
6. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis. Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J Acta Neurol Scand; 2013 Dec; 128(6):e33-6. PubMed ID: 23763388 [TBL] [Abstract][Full Text] [Related]
7. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia. Abdo WF; van de Warrenburg BP; Munneke M; van Geel WJ; Bloem BR; Kremer HP; Verbeek MM Neurology; 2006 Aug; 67(3):474-9. PubMed ID: 16894110 [TBL] [Abstract][Full Text] [Related]
8. The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA. Koel-Simmelink MJ; Vennegoor A; Killestein J; Blankenstein MA; Norgren N; Korth C; Teunissen CE J Immunol Methods; 2014 Jan; 402(1-2):43-9. PubMed ID: 24275679 [TBL] [Abstract][Full Text] [Related]
10. CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls. Pijnenburg YA; Janssen JC; Schoonenboom NS; Petzold A; Mulder C; Stigbrand T; Norgren N; Heijst H; Hack CE; Scheltens P; Teunissen CE Dement Geriatr Cogn Disord; 2007; 23(4):225-30. PubMed ID: 17290105 [TBL] [Abstract][Full Text] [Related]
11. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders. Constantinescu R; Rosengren L; Johnels B; Zetterberg H; Holmberg B Parkinsonism Relat Disord; 2010 Feb; 16(2):142-5. PubMed ID: 19647470 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica. Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620 [TBL] [Abstract][Full Text] [Related]
13. Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury. Rejdak K; Kuhle J; Rüegg S; Lindberg RL; Petzold A; Sulejczak D; Papuc E; Rejdak R; Stelmasiak Z; Grieb P Epilepsia; 2012 May; 53(5):922-7. PubMed ID: 22509781 [TBL] [Abstract][Full Text] [Related]
14. CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease. van Eijk JJ; van Everbroeck B; Abdo WF; Kremer BP; Verbeek MM J Alzheimers Dis; 2010; 21(2):569-76. PubMed ID: 20555148 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis. Hu X; Yang Y; Gong D Neurol Sci; 2017 Mar; 38(3):407-414. PubMed ID: 27896490 [TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study. Holmberg B; Johansson JO; Poewe W; Wenning G; Quinn NP; Mathias C; Tolosa E; Cardozo A; Dizdar N; Rascol O; Slaoui T; ; Mov Disord; 2007 Jun; 22(8):1138-44. PubMed ID: 17469198 [TBL] [Abstract][Full Text] [Related]
17. A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. Kuhle J; Regeniter A; Leppert D; Mehling M; Kappos L; Lindberg RL; Petzold A J Neuroimmunol; 2010 Mar; 220(1-2):114-9. PubMed ID: 20117845 [TBL] [Abstract][Full Text] [Related]
18. Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection. Petzold A; Groves M; Leis AA; Scaravilli F; Stokic DS Muscle Nerve; 2010 Jan; 41(1):42-9. PubMed ID: 19790244 [TBL] [Abstract][Full Text] [Related]
19. Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease. Constantinescu R; Romer M; Oakes D; Rosengren L; Kieburtz K Parkinsonism Relat Disord; 2009 Mar; 15(3):245-8. PubMed ID: 19056308 [TBL] [Abstract][Full Text] [Related]
20. Neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis. Sellner J; Davies NW; Howard RS; Petzold A Eur J Neurol; 2014 Jun; 21(6):845-50. PubMed ID: 24684186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]